---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-081575"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T06:14:44.096442+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics faces Nasdaq delisting after bid price below $1 for 30 days; cumulative reverse split ratio >250:1

## Summary
- Received Nasdaq notice Oct 27, 2023: bid price below $1 for 30 consecutive business days.
- Effected 1:35 reverse stock split on Mar 24, 2023 and 1:40 on Jun 28, 2023; cumulative ratio >250:1.
- Not eligible for 180-day compliance period due to prior reverse splits; delisting unless appeal is requested.
- Company intends to appeal; stock continues trading during appeal; delisting effective Nov 7, 2023 if no appeal.

## SEC filing metadata
- accession: 0001213900-23-081575
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/0001213900-23-081575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/ea187416-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-081575
- JSON: https://secwatch.observer/filing/0001213900-23-081575.json
- Plain text: https://secwatch.observer/filing/0001213900-23-081575.txt

## Key facts
- Listing & Compliance Notices
  Allarity Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)(iv)
  source text: October 27, 2023, we received notification from the Nasdaq Listing Qualifications staff that it has determined that the bid price of our Common Stock has closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Rule”). Further, the staff also noted that we effected an 1:35 reverse stock split on March 24, 2023, and an 1:40 reverse stock split on June 28, 2023. Because we effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one, we wil
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/0001213900-23-081575-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.